Frost & Sullivan has announced the availability of a research report entitled “Strategic Analysis of the Cell-Based Assays Market in Europe.”
The publication reports that “pharmaceutical, biotechnology, and drug discovery companies are increasingly turning their attention to cell-based assays, as these assays offer a more accurate representation of the real-life cell model than the traditional enzyme- or antibody-based assays,” Frost & Sullivan said in a statement.
The report also discusses a $143 million European cell-based assay market that is “expected to benefit most from the fluorescence assays segment, which is expected to contribute more than $75 million in revenue in 2004.”
Those interested in the report should send an email to Katja Feick ([email protected]) in corporate communications, Frost & Sullivan said.
BioInformatics LLC has published “Brand Perceptions of Life Science Instrumentation Suppliers.”
Based on a survey of more than 1,800 life scientists, the report provides an in-depth look at nine instrumentation categories, including centrifuges, DNA microarrays, and high-throughput screening instruments, BioInformatics said.
Those interested in the report can find further information on the company’s website, at http://www.gene2drug.com/reports.84.html, BioInformatics said.